galactosamine has been researched along with stilbenes in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Farghali, H; Kemelo, MK; Kutinová Canová, N; Wojnarová, L | 1 |
Farghali, H; Kgalalelo Kemelo, M; Kutinová Canová, N; Wojnarová, L | 1 |
Gong, XB; Jia, YN; Lu, HP; Pan, MH; Peng, YL; Su, J; Xu, L; Zhang, BS; Zhou, Y | 1 |
Li, S; Lin, H; Siu, FY; Ye, S | 1 |
Jia, A; Lin, H; Tao, L; Wen, J; Weng, D; Xu, X; Yang, Y; Zhang, J; Zhao, M | 1 |
Du, C; Jiang, A; Li, S; Liu, Z; Wang, J; Wu, D; Xie, G; Zhang, Y | 1 |
1 review(s) available for galactosamine and stilbenes
Article | Year |
---|---|
In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs.
Topics: Animals; Biomedical Research; Disease Models, Animal; Down-Regulation; Drug Discovery; Galactosamine; Humans; Lipopolysaccharides; Liver Failure, Acute; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes | 2016 |
5 other study(ies) available for galactosamine and stilbenes
Article | Year |
---|---|
D-galactosamine/lipopolysaccharide-induced hepatotoxicity downregulates sirtuin 1 in rat liver: role of sirtuin 1 modulation in hepatoprotection.
Topics: Animals; Antioxidants; Carbazoles; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Galactosamine; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes | 2014 |
Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Chemical and Drug Induced Liver Injury; Galactosamine; Heme Oxygenase-1; Hepatocytes; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Liver; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Morus; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NF-kappa B; Plant Extracts; Signal Transduction; Stilbenes; Toll-Like Receptor 4 | 2018 |
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Drug Liberation; Endocytosis; Galactosamine; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Male; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes | 2018 |
Piceatannol attenuates D-GalN/LPS-induced hepatoxicity in mice: Involvement of ER stress, inflammation and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Endoplasmic Reticulum Stress; Female; Galactosamine; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Stilbenes | 2018 |
Pterostilbene Exerts Hepatoprotective Effects through Ameliorating LPS/D-Gal-Induced Acute Liver Injury in Mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blotting, Western; Cytokines; Enzyme-Linked Immunosorbent Assay; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Protective Agents; Random Allocation; Real-Time Polymerase Chain Reaction; Stilbenes; Treatment Outcome | 2021 |